Thyroid gland explant cultures from prometamorphic Xenopus laevis tadpoles were evaluated for their utility in assessing chemicals for thyroid hormone (TH) synthesis disruption. The response of cultured thyroid glands to bovine thyroid stimulating hormone (bTSH) and the TH synthesis inhibitors methimazole, 6-propylthiouracil, and perchlorate was determined. Thyroid glands continuously exposed for 12 days to graded concentrations of bTSH released thyroxine (T4) in a dose-dependent manner. Over time, the glands appeared to reach a constant daily rate of T4 release. This suggested that the T4 stores in the glands were initially depleted but continuous release was maintained by synthesis of new hormone. The potency of methimazole, 6-propylthiouracil, and perchlorate for inhibiting T4 release was determined using glands cotreated with a single maximally effective bTSH concentration and graded concentrations of chemical. Inhibition of T4 release was dose dependent for all three chemicals. Perchlorate was the most potent inhibitor of T4 release. Methimazole and 6-propylthiouracil exhibited lower potency than perchlorate but similar potency to each other. The IC 50 (mean ± SD) for inhibition of T4 release by the thyroid glands was 1.2 ± 0.55, 8.6 ± 1.3, and 13 ± 4.0mM for perchlorate, 6-propylthiouracil, and methimazole, respectively. This model system shows promise as a tool to evaluate the potency of chemicals that inhibit T4 release from thyroid glands and may be predictive of in vivo T4 synthesis inhibition in prometamorphic tadpoles.
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The potential for chemicals to affect thyroid function is a toxicological concern for both humans and wildlife species (Boas et al., 2006; Brucker-Davis, 1998; Capen, 1994; DeVito et al., 1999; . This issue is being addressed by regulatory agencies (U.S. EPA, 1998) as part of different strategies to identify and assess the risks associated with endocrine disrupting chemicals. There is limited information regarding endocrine disrupting potential for most chemicals in commercial production and use. This lack of information has led to recommendations that assays, using mammalian and nonmammalian species, be developed to assess the endocrine disrupting potential of chemicals, especially for estrogen, androgen, and thyroid hormone (TH) systems (Gray et al., 2002; Huet, 2000) . Several mammalian-and amphibianbased in vivo assays have been proposed to specifically screen chemicals for effects on the hypothalamic-pituitarythyroid (HPT) axis (OECD, 2006; U.S. EPA, 2009a,b,c) . The mammalian assays in the Organisation for Economic Cooperation and Development Test Guidelines and the U.S. EPA Endocrine Disruptor Screening Program include measurement of serum THs, thyroid gland weights, and thyroid histology as their endpoints for thyroid disruption The amphibian metamorphosis assay designed to assess chemicals for TH disrupting activity is a 21-day continuous waterborne exposure assay starting with Xenopus laevis tadpoles at a stage of development near the onset of thyroid gland function. The endpoints measured after days 7 and 21 of exposure include hind limb length, snout-vent length, wet body weight, and metamorphic stage. Thyroid gland histology is also evaluated at day 21 upon termination of the test. Although these in vivo assays can identify chemicals that alter normal HPT axis function, the number of chemicals needing assessment and the expense of whole-animal assays suggest that assessing all the chemicals of concern using in vivo assays is not a feasible approach. Therefore, less costly alternatives that have higher throughput potential are needed to prioritize chemicals for testing; thereby focusing limited in vivo testing resources on potentially problematic chemicals.
Obtaining information on the proximate effects of chemicals on various components of the HPT axis would improve our understanding of how chemicals disrupt normal thyroid function. However, identifying the proximate effects of chemicals on the HPT axis in in vivo systems can be confounded by the homeostatic mechanisms within the organism that maintain normal circulating TH concentrations. Homeostatic control of TH is complex, involving not only the central components of the classical HPT axis but also peripheral physiological and regulatory processes, such as hepatic metabolism and localized tissue-specific TH regulation (Zoeller et al., 2007) . One approach to reducing this inherent complexity is to develop in vitro assays that are removed from the normal homeostatic feedback mechanisms and permit hypothesis testing. Such assays should be able to generate data on the effects of chemicals at specific regulatory points in the HPT axis and may provide for alternative in vitro approaches for screening and prioritization.
One in vitro system that holds promise as a tool for testing the thyroid toxicity of chemicals is thyroid gland explant cultures. Previous work has described such systems using thyroids from reptile and amphibian species (Denver and Licht, 1988; Sakai et al., 1991; Wright et al., 2000) . These studies have demonstrated that explanted thyroid glands are viable in culture and are responsive to thyroid stimulating hormone (TSH). Addition of exogenous TSH in the culture media results in quantifiable release of thyroxine (T4) into the media, thus providing a potential endpoint indicative of TH synthesis and release. These cultures have generally been of very short duration, with TSH stimulation and T4 release measured in less than 24 h, and they have not been optimized for use as a toxicological tool.
The goal of the present study was to develop, characterize, and evaluate X. laevis thyroid gland explant cultures as a tool for testing chemical inhibition of TH production. Using T4 release as the primary endpoint, the response of the glands to TSH stimulation was assessed and the parameters for evaluating the response of the glands to three known T4 synthesis inhibitors (methimazole, 6-propylthiouracil, and perchlorate) were defined.
MATERIALS AND METHODS
Animals. Xenopus laevis tadpoles were obtained from cultures maintained at the U.S. EPA, Mid-Continent Ecology Division, Duluth, MN, as described previously .
Chemicals. Leibovitz's L-15 medium (L-15) and antibiotic-antimycotic liquid (1003; penicillin, streptomycin, and amphotericin B) were purchased from Invitrogen (Carlsbad, CA). Bovine serum albumin (BSA), bovine TSH (bTSH), sodium bicarbonate, potassium iodide (KI), thyroxine (T4), methimazole (purity ! 98%), sodium perchlorate (purity > 99%), and 6-propylthiouracil (purity ! 99%) were purchased from Sigma (St Louis, MO). The bTSH was dissolved in sterile distilled water at 500 lg/ml (0.9 U activity/ml) and stored at À80°C in 100 ll aliquots for one-time use. Tricaine methanesulfonate (MS222) was purchased from Argent Laboratories (Redmond, WA).
General explant culture protocol. Tadpoles at developmental stage 58 or 59 (Nieuwkoop and Faber, 1994) were used for assay development because their glands were sufficiently large (~0.3-0.5 mm in diameter), relatively easy to dissect with fine forceps (#5 Dumont style; #72705; Electron Microscopy Sciences, Hatfield, PA), and responsive to bTSH stimulation such that a single gland per well of a 96-well plate released measurable amounts of T4. The thyroid of X. laevis develops into two distinct glands with their separation complete by stage 44 and each gland containing about 20 follicles (Coleman et al., 1968; Dodd and Dodd, 1976) . Thus, the term ''thyroid gland'' refers to one of the paired glands from a tadpole, and therefore, each tadpole can provide two glands for culture (See Supplementary fig. 1 ). Although the results are not presented here, glands from stage 55 tadpoles did respond to bTSH stimulation, but because of their smaller size, glands needed to be cultured as pairs in the 96-well plate wells and for longer culture times to obtain comparable T4 levels detectable by the immunoassay methods.
Prometamorphic tadpoles were anesthetized in buffered MS222 (150 mg MS222/l and 200 mg sodium bicarbonate/l). Dissections were conducted with the tadpole in phenol red-free L-15 media containing antibiotics and an antimycotic (100 U penicillin/ml, 100 lg streptomycin sulfate/ml, and 0.25 lg amphotericin B/ml) and 0.1% BSA. Thyroid glands were dissected free of the supporting cartilage and then placed in L-15 media containing antibiotic/ antimycotic, 0.1% BSA, and 1lM KI. The addition of KI to the culture media slightly increased T4 production and 1lM appeared to be a minimal concentration that gave increased T4 release following bTSH stimulation (data not shown). Therefore, L-15 media with antibiotics, BSA, and 1lM KI became the standard thyroid gland culture media used in all experiments. Following dissection, each gland was inspected for damage and any damaged glands were discarded. Any extraneous tissue that was dissected with the gland was removed without damaging the structure of the gland. Generally, an additional 10% extra glands were dissected above the minimum number required for an experiment, such that damaged glands, and very small or very large glands, could be discarded. The length and width of each gland was measured using an eyepiece reticle on the stereomicroscope. These data were used to sort the glands by an estimated volume that was calculated using the formula for an ellipsoidal volume, ( 4 / 3 )pabc, where a and b were the measured radii of the length and width of the gland, and the c radius was calculated as the mean of a and b. Glands at the extremes of the size range of glands, generally outside of 1 SD of the mean gland volume, were discarded and the remaining glands were randomized and assigned to treatment groups. To establish the utility of normalization to the gland volume estimate, several groups of glands were processed for protein determination by the bicinchoninic acid method (Smith et al., 1985) . Whether T4 release from glands was normalized to gland volume or gland protein, it did not alter the interpretation of the data or reduce the variability. Therefore, gland volumes were routinely used for normalization as this would allow the glands to be used later for gene expression analysis or histology if desired.
Following dissection and sorting, glands were placed overnight in 0.5 ml of L-15 media without bTSH in individual wells of a 24-well tissue culture plate. During this overnight incubation and throughout the course of all experiments, plates were placed in a 2.25-l covered plastic container containing wet paper towels to provide humidity. This container was placed on a rocker platform in a 21°C incubator with ambient air (Ambi Hi-Lo Chamber; LabLine, Melrose Park, IL). The following day, the glands were transferred in 2 ll total volume to a 96-well plate containing 100 ll of culture media per well with the appropriate concentration of bTSH. The bTSH concentrations used in the various experiments ranged from 125 to 4000 ng/ml, which corresponds to bTSH activity of 0.22-7.2 mU/ml, respectively. Control glands were incubated in culture media without bTSH. Glands were transferred every 24 or 48 h in 2 ll total volume into new wells containing 100 ll of fresh treatment media. After the glands were removed from the well, the remaining media was transferred into 0.5-ml polypropylene microcentrifuge tubes and stored at À80°C until analysis for T4 as described below.
Response of thyroid glands to bTSH and pituitary coculture. An initial experiment was conducted with paired thyroid glands from stage 58 tadpoles to determine their responsiveness to 500 or 1000 ng bTSH/ml for 24 or 48 h. Paired thyroid glands were also cocultured for 48 h in media with the pituitary gland from the same animal from which the paired thyroid glands were dissected. The media used for these coculture experiments contained no bTSH. This was done to determine if the release of T4 in response to bTSH stimulation would be similar to their responsiveness to TSH from X. laevis pituitary.
EX VIVO THYROID HORMONE DISRUPTION ASSAY
Because there was no available method to quantify X. laevis TSH, this experiment only provided general comparative information on the response of the glands to bTSH and their response when cocultured with X. laevis pituitary. The T4 released into the media by the thyroid glands after 24-or 48-h intervals was determined by ELISA as described below.
Comparison of T4 release among spawning pairs. One important consideration in the development of an explant culture assay for testing the activity of chemicals was the variability in response among spawns from different animals. To address this, four spawning pairs of adults were induced to spawn on the same day and when the tadpoles reached NF stage 59, the thyroid glands were dissected from the tadpoles and cultured in media containing 0, 500, or 2000 ng bTSH/ml for 48 h. The T4 released from the glands was determined by radioimmunoassay (RIA) as described below. Because of unequal variances among treatment groups, comparison of T4 release among different treatments was done by Kruskall-Wallis ANOVA on ranks, followed by a Dunn's multiple comparison test with significance set at p < 0.05.
Time and bTSH dependence of T4 release. An experiment was conducted to determine the responsiveness of the thyroid glands to bTSH stimulation over an extended time to evaluate how robust the explant gland cultures were. Thyroid glands from stage 59 tadpoles were cultured for 12 days in media containing no bTSH or graded concentrations of bTSH from 125 to 4000 ng/ml. Glands were cultured individually in wells of a 96-well plate with five replicate glands per treatment group. Glands were transferred in 2 ll total volume into new wells containing 100 ll fresh media every 24 h for the first 6 days and then every 48 h thereafter out to day 12. After each gland was transferred into a new well, the media remaining in the old well was transferred into 0.5-ml microcentrifuge tubes and stored at À80°C for T4 analysis by ELISA as described below.
Inhibition of T4 release: time dependence. The inhibition by methimazole of bTSH-stimulated T4 release from the cultured thyroid glands was determined using a single 10 mg/l concentration of methimazole and bTSH concentrations of 125, 250, 500, 1000, or 2000 ng bTSH/ml. Stock methimazole solution was prepared by dissolving neat chemical directly into prepared L-15 culture media. The appropriate amount of bTSH stock solution was added to aliquots of this to achieve the various bTSH treatment levels. This test media was frozen at À80°C in aliquots of appropriate volumes for one-time single use. These were thawed and used fresh as required for each experiment. Glands were transferred and media was sampled at time points as described above in the bTSH only experiment. The T4 released to the media was measured by ELISA as described below. The response data for the methimazole inhibition over 12 days were log transformed and analyzed by t-test at each day to determine when inhibition first became significant. Where log transformation did not normalize the data or equalize the variance between groups, the Mann-Whitney Rank Sum test was used with significance set at p < 0.05.
A comparison of this time dependence of inhibition of T4 release was also determined for 6-propylthiouracil and perchlorate. Unlike the previous experiment, inhibition of T4 release was determined using a maximal inhibitory concentration of chemical (methimazole and 6-propylthiouracil each at 100 mg/l or perchlorate at 10 mg/l) and a single maximal stimulatory concentration of bTSH (2000 ng/ml) throughout the duration of the culture. These data were normally distributed and of equal variance so were analyzed by ANOVA, followed by the Dunnett's post hoc test with significance set at p < 0.05.
Inhibition of T4 release: potency comparison. Full dose-response curves were generated for the inhibition of T4 release by methimazole, 6-propylthiouracil, and perchlorate. Stock solutions were prepared by dissolving neat chemical directly into prepared L-15 culture media, and serial dilutions were made with L-15 culture media. Chemical concentrations ranged from 0.1 to 10 mg/l (0.88-88lM) for methimazole, 0.15-15 mg/l (0.88-88lM) for 6-propylthiouracil, and 0.005-5 mg/l (0.04-44lM) for perchlorate. Each test solution received bTSH at 2000 ng/ml and then was frozen at À80°C in aliquot volumes for one-time single use. For these experiments, controls were glands cultured in media containing 2000 ng bTSH/ml and no T4 synthesis inhibitor. The three chemicals were tested in separate 96-well plates with each plate containing 10 individual glands per each treatment level of chemical or controls with bTSH alone. Based upon the results of the previous experiments, exposure media was changed every 48 h on days 2, 4, and 6. On day 8, the experiment was terminated, and the media collected on day 8 was analyzed by RIA for the cumulative T4 released to the media over the last 48 h in culture. The IC 50 values for inhibition of T4 were determined by fitting the inhibition curves to a sigmoidal variable slope curve in SigmaPlot 9.01/SigmaStat v3.
Total T4 determination. Culture media was analyzed for total T4 using commercially available immunoassay kits: T4 Total ELISA (96-well plate format; MP Biomedicals, Irvine, CA) and Total T4 Canine RIA Coat-A-Count Kit ( 125 I-thyroxine; 13 3 100 mm tube format; Diagnostic Products Corporation. Los Angeles, CA). For each of these methods T4 standards were prepared in the same L-15-based media matrix as that used for the gland culture experiments to avoid any differences in matrix effects between the standards and the samples. T4 standards were prepared from a stock solution of T4 prepared in 0.1 N NaOH at 590 lg T4/ml. A 3000 ng T4/ml working standard was prepared by adding 5 ll of T4 stock solution and 5 ll of 0.1 N HCl to 990 ll L-15 culture media (final pH 7.4). This 3000 ng T4/ml working stock was used to prepare serial dilutions in culture media from 0.3 to 1000 ng T4/ml at half-logarithm concentration steps. Twenty-five microliters of sample or standard were used in each assay. The limit of detection for both methods was 2.2 ng T4/ml as determined by fitting the standard curve to a fourparameter logistic function using SigmaPlot/SigmaStat. In our experience, the lot-to-lot variability of EC 50 values was greater for the ELISA than the RIA, so later experiments were conducted exclusively by RIA. Except for substituting the T4 serum standards provided in the kits with the T4 standards prepared as described above, the ELISAs and RIAs were conducted according to the manufacturer's instructions. Absorbance values from the ELISAs were read at 450 nm (Model 3550 Microplate Reader; BioRad, Hercules, CA).
125
I radioactivity was determined using a WIZARD 1470 Gamma Counter (Perkin Elmer, Boston, MA). ELISA and RIA standard curves were plotted and analyzed by four-parameter logistic function in SigmaPlot/SigmaStat software (SysStat, Point Richmond, CA) and the T4 concentrations in the media samples were calculated from this curve. Although there was good agreement between ELISA and RIA determinations of T4 in T4 spiked media samples, no comparisons of results are made between experiments in which T4 was measured by different methods.
Histology. The integrity of the glands during extended culture was verified by histology. A subset of glands cultured for 8 days in control media containing no bTSH, media with 1000 ng TSH/ml, or media with 1000 ng bTSH/ml and 10 mg methimazole/ml were fixed with 10% neutral buffered formalin for 90 min, rinsed in phosphate buffered saline, and processed by hand through an ethanolic series for embedding in JB-4 plastic according to the manufacturers directions (Electron Microscopy Sciences). Sections (3 lm thickness) were cut at 25-lm steps into the gland. Sections were stained with hematoxylin and eosin.
RESULTS

Response of Thyroid Glands to bTSH and Pituitary Coculture
Thyroid glands were dissected from stage 58 tadpoles and cultured in 100 ll of media at a density of two glands per well. Thyroid glands treated with bTSH released T4 into the media in dose-dependent manner, whereas the control glands (i.e., no bTSH) did not release measurable quantities of T4 (Fig. 1) . The mean concentration of T4 in the media was 98 and 156 ng T4/ml when glands were treated for 24 h with 500 or 1000 ng bTSH/ml, respectively. Treatment with bTSH for 48 h at 500 or 44 HORNUNG ET AL. 1000 ng/ml resulted in T4 concentrations in the media of 183 and 320 ng T4/ml, respectively. Thyroid gland pairs cocultured with the pituitary gland from the same tadpole released T4 into the media at a mean concentration of 232 ng T4/ml by 48 h. Thus, the coculture of paired thyroids with a pituitary resulted in media T4 concentrations intermediate to that released by glands treated with 500 or 1000 ng bTSH/ml.
Comparison of T4 Release among Spawning Pairs
To determine the variability in response among spawns, four pairs of adults were separately spawned on the same day. The thyroid glands from tadpoles from those spawns were used to test for the response to TSH stimulation for 48 h. For all four spawns, individual glands cultured in control media without bTSH did not release any T4, whereas there was a dosedependent release of T4 in response to bTSH stimulation (Fig. 2) . The T4 released by individual glands treated with 2000 ng bTSH/ml was greater than that from glands treated with 500 ng bTSH/ml. The difference based upon concentration of T4 in the media ranged from 2.1-fold for spawn C (29 vs. 60 ng T4/ml) to 5.3-fold for spawn A (16 vs. 85 ng T4/ml) for the 500 versus 2000 ng bTSH/ml treatments, respectively. No significant differences were found among spawns within a bTSH treatment level
Time and bTSH Dependence of T4 Release
Thyroid glands dissected from stage 59 tadpoles were cultured for 12 days with media changes at daily intervals for the first 6 days and every other day thereafter. The T4 released to the media in response to bTSH stimulation was dose dependent (Fig. 3) . Glands cultured in media without bTSH did not release detectable T4. Only a few glands cultured in 125 ng bTSH/ml released detectable T4 on only a few days. Significant T4 release was initially detected at bTSH concentrations of 250 ng/ml and release of T4 was fairly constant over the course of the experiment. The initial 24-h treatment in 250 ng bTSH/ml yielded a T4 concentration in the 100 ll of culture media of 3.13 ± 0.67 ng T4/ml (mean ± SD; n ¼ 5), which was just above the limit of detection of the assay. The T4 concentration released into the culture media for the next 5 days thereafter averaged 5.2 ± 1.6 ng T4/ml/day. When normalized to estimated gland volume, the mean daily T4 release from days 1 FIG. 1. Cumulative T4 released from paired thyroid glands in response to 500 or 1000 ng bTSH/ml or when cocultured with a pituitary gland from the same tadpole. Thyroid glands were dissected from stage 58 tadpoles and cultured as pairs for 24 or 48 h with no bTSH (no T4 detected; detection limit ¼ 0.2 ng T4/pair of glands), 500 or 1000 ng bTSH/ml. Paired thyroid glands were also cultured with the pituitary from the same animal for 48 h. Bars represent mean and SD of n ¼ 5 pairs of glands. 
FIG. 3.
Cumulative T4 released in response to graded concentrations of bTSH. Glands from stage 59 tadpoles were transferred to fresh media each day for the first 6 days and then every other day thereafter. Media from the previous culture interval was sampled for T4 analysis by ELISA. Measured T4 was normalized to the estimated gland volume determined on day 0. Symbols represent mean and SD of n ¼ 5 wells with one gland per well. Data were fit to a three-parameter power function using SigmaPlot/SigmaStat. EX VIVO THYROID HORMONE DISRUPTION ASSAY to 6 ranged from 10 to 22 ng T4/mm 3 gland/day and dropped to a mean of 7.4 ng T4/mm 3 gland/day from days 7 to 12. For the first 6 days, the 500 ng TSH/ml group released a mean of 52 ng T4/mm 3 gland/day. This corresponded to a mean of 18 ng T4/ ml/day measured in the media in the wells. At bTSH concentrations of 1000 ng/ml and above, the initial release of T4 to the culture media was at a higher rate for the first day, after which the rate of release decreased. The concentrations of T4 measured in the media in the first 24 h following initiation of culture in the 1000, 2000, and 4000 ng bTSH/ml treatment groups were 18.5 ± 7.2, 34.3 ±16.3, and 30.6 ± 22.2 ng T4/ml, respectively. The rate of T4 release from days 6 to 12 was similar for the 500, 1000, and 4000 ng/ml groups at 24, 30, and 30 ng T4/mm 3 gland/day, respectively. Glands cultured in 2000 ng bTSH/ml released 53 ng T4/mm 3 /gland/day from days 6 to 12. Although it appears from the figure that the 4000 ng bTSH/ml group had a lower rate of T4 release than the 2000 ng bTSH/ml group over time, their initial T4 release means within the first 24 h was the same and the 4000 ng bTSH group released only slightly less T4 than did the 2000 ng bTSH group thereafter. The cumulative T4 released was not significantly different between the 2000 and 4000 ng bTSH groups at any time point as determined by t-test on each day.
Inhibition of T4 Release: Time Dependence
Inhibition of T4 release was examined using a single 10 mg/l concentration of methimazole with graded concentrations of bTSH over several days of culture (Fig. 4) . At the two lowest bTSH concentrations, 125 and 250 ng bTSH/ml, there was no measurable inhibition of T4 release to the media when cultured with methimazole (not shown). At 500 ng TSH/ml, significant inhibition was detected at day 6 (Fig. 4A) . With greater bTSH concentrations, the inhibition of T4 release by methimazole occurred earlier, at days 5 and 3, at 1000 ng bTSH/ml (Fig. 4C ) and 2000 ng bTSH/ml (Fig. 4E) , respectively.
The time dependence for inhibition by 6-propylthiouracil and perchlorate was also determined in parallel with methimazole using thyroid glands from stage 59 tadpoles. The time dependence for inhibition with the three model chemicals was similar (Fig. 5) . There was no significant inhibition of T4 release after 2 days of culture, but significant inhibition was detected by day 4 and persisted until the end of the 8-day exposure.
Inhibition of T4 Release: Potency Comparison
After determining that inhibition of T4 release by these chemicals does not become significant until after several days of culture, thyroid glands from stage 59 tadpoles were treated with a single high concentration of bTSH (2000 ng bTSH/ml) and with graded concentrations of methimazole, perchlorate, or 6-propylthiouracil for 6 days with replacement of treatment solution every 48 h. The cumulative T4 released for the 48-h interval from days 6 to 8 was measured by RIA (Fig. 6) . The cumulative T4 released to the media in this 48-h interval by glands stimulated with 2000 ng bTSH/ml alone (controls) was 39 ± 19, 33 ± 16, and 44 ± 19 ng T4/ml/48 h for those control glands in the 96-well plates containing the perchlorate, 6-proplythiouracil, or methimazole treatments, respectively. Each of these three chemicals was capable of fully inhibiting T4 release to nondetectable levels in this days 6-8 interval (Fig. 6 ). Under these experimental conditions, perchlorate was the most potent inhibitor of T4 release with an IC 50 of 1.2lM (0.15 mg/l). 6-Propylthiouracil and methimazole exhibited inhibitory potencies similar to each other, with calculated IC 50 values of 8.6lM (1.5 mg/l) and 13lM (1.5 mg/l), respectively.
Gland Histology
Thyroid gland histology was assessed on glands following 8 days of culture in control media, media with bTSH, or media with bTSH and methimazole (Fig. 7) . The interior follicles showed no evidence of necrosis or damage and the glands appeared to maintain their morphological integrity throughout the duration of the culture. The bTSH-treated glands (Figs. 7C and 7F) showed some evidence of follicular cell hypertrophy compared with the predominantly cuboidal follicular cells in the control glands (Fig. 7D) . The effects seen in the glands appeared to be related to bTSH treatment and not methimazole treatment, as the glands treated with bTSH alone (Figs. 7B and 7E ) or with bTSH and methimazole (Figs. 7E and 7F) did not appear different from each other but were different from the control glands cultured in the absence of bTSH (Figs. 7A and 7D ).
DISCUSSION
Thyroid gland explant cultures provide an alternative in vitro system for assessing the ability of chemicals to disrupt normal TH production and release and can provide information to help interpret the effect of chemicals on the HPT axis in the tadpole in vivo. The X. laevis thyroid gland explants responded to bTSH in a dose-dependent manner for T4 release. Inhibition of T4 release was also time and dose dependent for chemical inhibitors of TH synthesis. These results demonstrate the utility of this assay as a tool to assess the effects of chemicals on the normal function of the gland itself when isolated from the intact HPT and held in favorable culture conditions.
An interesting finding in this study was the difference in magnitude between the initial rate of T4 release and the prolonged rate of T4 release when stimulated with high concentrations of bTSH. This may be an indication of differences between the release of stored T4 versus newly synthesized T4. Release of T4 to the media following stimulation with high concentrations of bTSH was initially quite high. This was followed by a decrease in daily T4 release to a stable level that was then maintained for several days (Figs. 3 and 4) . The 46 HORNUNG ET AL. capacity of the gland to continue to release T4 in the presence of the T4 synthesis inhibitor methimazole, albeit at significantly reduced levels, further suggests that there was ample reserve of stored T4 to reduce the apparent impact of synthesis inhibition on T4 release (Fig. 4) . This is further supported by the observation that methimazole was unable to significantly inhibit release of T4 at low concentrations of bTSH (125 and 250 ng bTSH/ml). In this case, stored T4 was likely sufficient to maintain the lower T4 release rate associated with these bTSH concentrations. However, this study did not explicitly determine the degree of T4 synthesis inhibition by any of the chemicals, an effect which could be influenced by culture conditions or the efficacy of the in vitro exposure. Therefore, determining the relative contribution of stored T4 to nascent T4 to that observed in the media remains an uncertainty that requires additional investigation.
One might postulate that the high levels of T4 released into the media initially by the higher bTSH treatment levels could have had an inhibitory effect on further T4 release and that is why the T4 output dropped off to reduced levels in these glands. However, if T4 in the media depressed the responsiveness to TSH, then when the gland was transferred to fresh T4-free culture media after 48-h intervals, it might be expected to recover. Because the glands did not release T4 to these high levels again suggests that this was not the case. Alternatively, the glands may have become desensitized to TSH stimulation at these high concentrations producing the drop in T4 release seen after the initial 24 h, although this might be a very rapid response in this in vitro system compared with the desensitization that has been reported to occur after TSH stimulation (Dumont et al., 1992) . Different responses in thyroid glands have also been shown to be dependent upon the concentration of TSH (Allgeier et al., 1994; Raspé et al., 1991) . In human thyroid slices, low levels of TSH activate adenylyl cyclase pathways ultimately affecting growth, differentiation, and hormone secretion, whereas at higher concentrations, TSH stimulates phospholipase C-mediated pathways that activate H 2 O 2 production and iodination (Kopp, 2001) . Whether these types of biphasic factors are affecting, the TSH responsiveness and/or the amount of T4 released by these X. laevis thyroid glands in culture is unknown and would require further investigation.
These thyroid gland explant experiments provide insights into the stage-specific dependency of metamorphic inhibition of X. laevis. The X. laevis tadpole at stage 60 is insensitive to inhibition of metamorphosis by perchlorate, an iodide uptake FIG. 4 . Inhibition of T4 release by methimazole over time plotted as daily (A, C, and E) or cumulative T4 release (B, D, and F) for glands treated with 500 ng bTSH/ml (A and B), 1000 ng bTSH/ml (C and D), or 2000 ng bTSH/ml (E and F). Asterisks indicate the first day of bTSH treatment for each group that the daily T4 production was significantly inhibited by methimazole. Symbols and bars represent mean and SD of n ¼ 5 glands per treatment group.
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inhibitor, but if exposure begins at stage 51 or 54, metamorphosis can be arrested (Goleman et al., 2002; Tietge et al., 2005) . The prolonged release of T4 by thyroid glands in vitro suggests that with TSH stimulation, the glands release much of their thyroglobulin-bound T4 and there is a significant reserve of T4 in the glands at these stages. By exposing tadpoles at early prometamorphic stages, their thyroid glands are smaller and likely have less T4 reserves than thyroid glands in later prometamorphic stages. These tadpoles may quickly use up their limited T4 reserves and with synthesis stopped or greatly reduced, circulating T4 concentrations cannot be maintained at sufficient concentrations for metamorphosis to proceed. Exposure to T4 synthesis inhibitors at later prometamorphic stages can stop the formation of new T4, but the glands have sufficient stores of T4 such that continued TSH stimulation maintains circulating T4 concentrations to drive the tadpole through metamorphosis.
Recent measurements of circulating T4 and T4 within the thyroid glands of X. laevis tadpoles exposed beginning at stage 54 further support this interpretation (Tietge et al., 2010) . In these studies, tadpoles were continuously exposed to perchlorate, 6-propylthiouracil, or methimazole at a single high concentration sufficient to completely inhibit metamorphosis. Glandular T4 in the tadpoles exposed to the T4 synthesis inhibitors was decreased at 2 days following the start of the exposure, but circulating T4 was not decreased until day 6. These studies demonstrate that the effect on T4 synthesis occurs prior to an effect on T4 release, supporting the argument that although T4 synthesis may be inhibited, the thyroid glands have the capacity to maintain normal levels of T4 release. Other authors have also reported that the thyroid gland has a capacity to release and maintain normal circulating T4 levels even in the presence of T4 synthesis inhibition. Genistein has been shown to be potent inhibitor of thyroid peroxidase (TPO) in vitro, which would suggest that exposure in vivo would lead to TH insufficiency. However, dietary exposure of newborn rats for 20 weeks did not produce evidence of hypothyroidism, leading the authors to speculate that a minimal level of TPO is maintained that is sufficient to maintain T4 synthesis and T4 serum concentrations at normal levels (Chang and Doerge, 2000) .
The explant culture assays may also give some indication of effects of different mechanisms of T4 synthesis inhibition. Methimazole and 6-propylthiouracil inhibit T4 synthesis by inhibiting TPO enzyme, which catalyzes the iodination and coupling of tyrosines of thyroglobulin (Nagasaka and Hidaka, 1976) . The concentration response curves for inhibition of T4 release from the thyroid gland explants show similar slopes with both these chemicals. Perchlorate on the other hand inhibits T4 synthesis by blocking uptake of iodide into the thyroid gland via the sodium iodide symporter (NIS) protein (Wolff, 1998) . The concentration response inhibition curve for this chemical has a shallower slope than those for methimazole and 6-propylthiouracil. In addition, the IC 50 for perchlorate is similar to the 1lM concentration of KI supplemented in the culture media. This suggests that the IC 50 for NIS inhibitors in this assay system will correlate with the concentration of iodide in the culture media.
Inhibition of TH release in thyroid gland explant cultures occurred at similar, or slightly lower, methimazole concentrations than what was observed to affect the thyroid gland in vivo. Exposure of stage 51 and 54 tadpoles to methimazole in vivo produced morphological effects on the thyroid at 12.5 mg/l after 8-day exposure . These effects included follicular cell hypertrophy and hyperplasia. In the thyroid gland explant cultures, the IC 50 for inhibition of FIG. 5 . Time-dependent inhibition of T4 release by methimazole, 6-propylthiouracil, and perchlorate. Glands were treated with 2000 ng TSH/ml alone, bTSH and 100 mg/l methimazole bTSH and 100 mg/l 6-propylthiouracil, or bTSH and 10 mg/l perchlorate. Bars indicate mean and SD of five replicates per treatment group. Asterisks indicate significantly less T4 released compared to bTSH alone at that time point (p < 0.05). T4 release by methimazole was 1.5 mg/l. Thus, the thyroid gland explant cultures respond at similar concentrations that produce effects in vivo and therefore would provide an excellent in vitro format for testing more chemicals for their potential to affect TH synthesis. These in vitro to in vivo comparisons must also be made with the caveat that the circulating TSH levels in vivo are unknown. The IC 50 s for methimazole (13lM) and 6-propylthiouracil (8.6lM) determined in this study for inhibition of T4 release are in a similar concentration range as those determined for TPO inhibition using thyroid microsomal proteins or recombinantly expressed TPO. Nagasaka and Hidaka (1976) reported the IC 50 s for TPO inhibition in human thyroid glands as 0.8 and 2lM for methimazole and propylthiouracil, respectively. The IC 50 values for these two chemicals in preparations from porcine thyroid glands were also near 1lM (Engler et al., 1982) . More recently, recombinantly expressed human TPO in FTC238 human thyroid carcinoma cells produced IC 50 s for methimazole and propylthiouracil of 10 and 100lM, respectively . Thus, the sensitivity of the thyroid explant culture assay for detecting T4 synthesis inhibitors appears to be similar to assays that specifically measure the inhibition of the enzyme that catalyzes T4 synthesis.
Understanding the time dependence of T4 release in response to TSH was essential to develop the thyroid gland explant culture assay to be used to test the inhibitory effect of chemicals on TSH-stimulated T4 release. The assay as described here demonstrates that a 6-day period of continual TSH stimulation and cotreatment with inhibitor to ''purge'' much of the stored T4 from the glands and inhibit new T4 synthesis is necessary. Culture over the next 48 h with TSH and test chemical should allow for determination of whether chemicals may affect T4 production and release, and this effect is independent of whether the mechanism is via inhibition of TPO enzyme or inhibition of iodide uptake into the gland. In addition, to compare the effects of chemicals tested at different times with different spawns, a positive control such as the potent T4 synthesis inhibitor methimazole could be run in parallel with the test chemical(s). In the context of all the steps necessary for the thyroid gland to function to produce hormone-from iodide uptake, enzymatic iodination of thyroglobulin, uptake of thyroglobulin, and processing of hormones until final release-it is important not to lose sight of the main objective of this assay which is to assess if a chemical has the potential to have a direct effect on the thyroid gland to disrupt TSH-mediated TH synthesis and release.
Histological analysis of the explanted thyroid glands after 8 days indicates that the glands are a very robust system in culture. The glands appear intact with no signs of necrosis. The morphology of the explanted thyroid glands did not show as severe effects as was expected based upon the effects of T4 synthesis inhibitors on the glands in vivo. Glands in culture with 1000 ng bTSH/ml for 8 days exhibited slight follicular cell hypertrophy but little or no hyperplasia. The hypertrophy observed here was not as profound as might have been expected based upon the gross hypertrophy reported from tadpoles in vivo exposed to 25 mg methimazole/l, although the glands in culture are not entirely unlike those with less severe hypertrophy and hyperplasia as seen at 12.5 mg methimazole/l in vivo . One caveat in making this comparison of gland histology between the in vivo and FIG. 7. Thyroid gland morphology after 8 days in culture. Glands were cultured in control media with no bTSH (A and D), media with 1000 ng bTSH/ml (B and E), or media with 1000 ng bTSH/ml and 10 lg/ml methimazole (C and F). Arrows indicate examples of cuboidal follicular cells in control glands (D) or hypertrophic columnar follicular cells in glands treated with bTSH alone (E) or bTSH and methimazole (F). Scale bars indicate 50 lm in all panels.
in vitro studies is that TSH serum concentrations that resulted from the inhibitor exposures in vivo are not known, so the in vivo responses cannot be directly compared with the in vitro responses. A more thorough evaluation of the morphological response of the glands to TSH treatment is required to determine whether the apparent lack of severe hyperplasia in the explanted glands is because of insufficient bTSH to stimulate hyperplasia, different responsiveness of the glands to bTSH versus X. laevis TSH, time-related effects, or whether additional components such as growth factors are also required in the media to stimulate hyperplasia (Kimura et al., 2001) .
In summary, thyroid gland explant cultures provide an excellent tool for understanding the effects of chemicals at this specific node in the HPT axis. The characteristics of T4 release by the cultured thyroid glands in this study suggest that the glands have a reserve of T4 that is released upon stimulation with TSH. Understanding the time course of T4 release enables this system to be used to test the direct inhibitory effect of chemicals on T4 release from the gland. Whereas other assays may have higher throughput potential than this assay and they may assess specific nodes within the thyroid gland, such as iodide uptake (Cianchetta et al., 2010) or TPO activity using tissue derived enzymes or recombinantly expressed enzymes (Engler et al., 1982 , the thyroid explant culture assay maintains the integrated effect of chemicals at multiple points within the thyroid gland necessary for TH synthesis and release. This assay can be used to provide a simple yes or no answer regarding the capacity of a chemical to alter TSH-stimulated TH release, or it can be used to establish full dose-response data to compare the relative potency with the known thyroid inhibitors presented in this study. This information can then be used to select chemicals for further evaluation in vivo if warranted. Finally, the utility of in vitro assays for interpreting in vivo results was demonstrated by the finding of the capacity of the glands to release stored T4, which provides an explanation for the stage sensitivity of the effects of T4 synthesis inhibitors for arresting metamorphosis. This system, and isolated in vitro tissue culture systems in general, can aid the interpretation of chemical effects in vivo, which can lead to more informed decisions regarding the relative risk of chemicals in the environment.
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